WHO has commenced review process for Emergency Use Listing of Covaxin: Govt
Image Credit: Shortpedia
All documents required for Emergency Use Listing (EUL) have been submitted to WHO by Bharat Biotech for COVID-19 vaccine Covaxin as of July 9 and the review process by the agency has commenced, Minister of State for Health Bharati Pravin Pawar told Rajya Sabha on Tuesday. The review process by WHO has commenced. WHO usually takes up to six weeks to decide on Emergency Use Listing (EUL) submissions, she said in a written reply.